Drawing for ELITE BEGENIUS

USPTO serial 79289674

ELITE BEGENIUS

Reviewed by CopyMark Law Group

Reg. 6926716Status 700Registered
Filing date
Status date
Registration date
Dec 20, 2022
Examiner
LAM, HAI-LY HUYNH
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ELITE BEGENIUS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

BRUCE S. LONDA

BRUCE S. LONDA NORRIS, MCLAUGHLIN, P.A.7 TIMES SQUARE21ST FLOORNEW YORK, NY 10036

Goods and services

ClassDescriptionStatusFirst use
009Research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; scientific apparatus and instruments, namely, fluid handling device used for disposable bioprocessing applications and parts and fittings therefor; diagnostic apparatus for the detection of pathogens for laboratory or research use; none of the foregoing for use in the field of breast health using medical imaging apparatuses, devices, equipment, and software, or in the field of cytology for cancer screening or detectionACTIVE—
010Laboratory apparatus for medical diagnostic purposes, namely, apparatus for clinical diagnosis, to be used by health care professionals in the field of molecular biology in order to diagnose infectious diseases; automatic analyzers for bacterial identification for medical diagnosis; analyzers for bacterial identification for medical purposes; medical apparatus, namely, diagnostic instruments for performing DNA assays, extraction, amplification, and detection; none of the foregoing for use in the field of breast health using medical imaging apparatuses, devices, equipment, and software, or in the field of cytology for cancer screening or detectionACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 12, 2026CHLDCHANGE OF OWNER RECEIVED FROM IB—
Nov 17, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 24, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 3, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 3, 2023FIMPFINAL DISPOSITION PROCESSED—
Mar 20, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 17, 2023LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Dec 20, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 20, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 15, 2022TMBNTTAB RELEASE CASE TO TRADEMARKS—
Nov 15, 2022OP.TOPPOSITION TERMINATED NO. 999999—
Nov 15, 2022OP.DOPPOSITION DISMISSED NO. 999999—
Oct 30, 2022LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Jan 10, 2022OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Dec 22, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 22, 2021OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Nov 28, 2021RFNPREFUSAL PROCESSED BY IB—
Nov 5, 2021OP.IOPPOSITION INSTITUTED NO. 999999—
Nov 2, 2021OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB—
Nov 2, 2021OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED—
Jun 2, 2021ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
May 4, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 4, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 2, 2021GPNXNOTIFICATION PROCESSED BY IB—
Apr 14, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 14, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Apr 14, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 26, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 17, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 16, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 16, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 12, 2021CHLDCHANGE OF OWNER RECEIVED FROM IB—
Oct 19, 2020RFNTREFUSAL PROCESSED BY IB—
Sep 26, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 25, 2020RFRRREFUSAL PROCESSED BY MPU—
Aug 28, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 27, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 25, 2020DOCKASSIGNED TO EXAMINER—
Jul 28, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 23, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 22, 2020LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jul 16, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance